APA (7th ed.) Citation

Foinquinos, A., Batkai, S., Genschel, C., Viereck, J., Rump, S., Gyöngyösi, M., . . . Thum, T. (2020). Preclinical development of a miR-132 inhibitor for heart failure treatment. Nature communications, 11(1), 633-10. https://doi.org/10.1038/s41467-020-14349-2

Chicago Style (17th ed.) Citation

Foinquinos, Ariana, et al. "Preclinical Development of a MiR-132 Inhibitor for Heart Failure Treatment." Nature Communications 11, no. 1 (2020): 633-10. https://doi.org/10.1038/s41467-020-14349-2.

MLA (9th ed.) Citation

Foinquinos, Ariana, et al. "Preclinical Development of a MiR-132 Inhibitor for Heart Failure Treatment." Nature Communications, vol. 11, no. 1, 2020, pp. 633-10, https://doi.org/10.1038/s41467-020-14349-2.